πŸ‡ΊπŸ‡Έ FDA
Patent

US 12162870

Anticancer compounds

granted A61KA61K45/06A61P

Quick answer

US patent 12162870 (Anticancer compounds) held by The Regents of the University of California expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K45/06, A61P, A61P35/00